US Bancorp
MRVI icon

US Bancorp’s Maravai LifeSciences MRVI Stock Holding History

US Bancorp’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.23K Sell
998
-23
-2% -$99 ﹤0.01% 3592
2026
Q1 		$2.89K Buy
1,021
+77
+8% +$261 ﹤0.01% 3719
2025
Q4 		$3.07K Sell
944
-943
-50% -$3.17K ﹤0.01% 3668
2025
Q3 		$5.42K Hold
1,887
– – ﹤0.01% 3516
2025
Q2 		$4.55K Buy
1,887
+828
+78% +$1.74K ﹤0.01% 3670
2025
Q1 		$2.34K Sell
1,059
-2,757
-72% -$10.9K ﹤0.01% 3848
2024
Q4 		$20.8K Buy
3,816
+97
+3% +$624 ﹤0.01% 3136
2024
Q3 		$30.9K Buy
3,719
+264
+8% +$2.28K ﹤0.01% 2955
2024
Q2 		$24.7K Sell
3,455
-88
-2% -$760 ﹤0.01% 2976
2024
Q1 		$30.7K Sell
3,543
-410
-10% -$2.77K ﹤0.01% 2923
2023
Q4 		$25.9K Buy
3,953
+681
+21% +$4.4K ﹤0.01% 2940
2023
Q3 		$32.7K Buy
3,272
+2,360
+259% +$25.9K ﹤0.01% 2643
2023
Q2 		$11.3K Sell
912
-5,097
-85% -$68.8K ﹤0.01% 3215
2023
Q1 		$84.2K Buy
6,009
+2,472
+70% +$35.5K ﹤0.01% 2273
2022
Q4 		$50.6K Sell
3,537
-17,865
-83% -$281K ﹤0.01% 2520
2022
Q3 		$547K Sell
21,402
-31,254
-59% -$784K ﹤0.01% 1348
2022
Q2 		$1.5M Buy
52,656
+52,555
+52,035% +$1.66M ﹤0.01% 928
2022
Q1 		$4K Sell
101
-56
-36% -$1.88K ﹤0.01% 3678
2021
Q4 		$6K Sell
157
-417
-73% -$16.9K ﹤0.01% 3592
2021
Q3 		$28K Sell
574
-4
-0.7% -$195 ﹤0.01% 2948
2021
Q2 		$24K Buy
578
+534
+1,214% +$20.7K ﹤0.01% 3044
2021
Q1 		$1K Hold
44
– – ﹤0.01% 3805
2020
Q4 		$1K Buy
+44
New +$1.23K ﹤0.01% 3681

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
1WCM
12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OAM
Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

US Bancorp's MRVI Position: Q2 2026 in Review

US Bancorp reduced its Maravai LifeSciences (MRVI) stake by 2.3% in Q2 2026, selling an estimated $99 and leaving 998 shares worth $6.23K. The position accounts for ﹤0.01% of the portfolio, ranked #3592.

US Bancorp first reported a position in MRVI in Q4 2020 and has held it in 23 quarters since. The position peaked at $1.5M in Q2 2022. 178 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

  • US Bancorp held 998 shares of Maravai LifeSciences worth $6.23K as of Q2 2026.
  • US Bancorp sold 23 Maravai LifeSciences shares in Q2 2026, an estimated $99.
  • Maravai LifeSciences made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #3592 holding.
  • US Bancorp first reported a position in Maravai LifeSciences in Q4 2020 and has held it in 23 quarters since.
  • US Bancorp's Maravai LifeSciences position peaked at $1.5M in Q2 2022.
  • 178 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.